Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 5 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia
Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia
Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia
Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia
Acupuncture Point Stimulation for Treatment of Chemotherapy Nausea and Vomiting